Overview

A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis

Status:
Completed

Trial end date:
2015-07-01

Target enrollment:

Participant gender:

Summary

This study will compare the effect of denosumab produced by two different manufacturing processes on bone mineral density at the lumbar spine in postmenopausal women with osteoporosis.

Phase:

Phase 3

Details

Lead Sponsor:

Amgen

Treatments:

Denosumab